Macquarie Group’s GoHealth GOCO Stock Holding History

Macquarie Group’s Portfolio GOCO Stock Details GOCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,932	Closed	-$146K	–	2622
2021 Q3	$146K	Buy	1,932 +1,818	+1,595%	+$192K	﹤0.01%	1863
2021 Q2	$19K	Hold	114	–	–	﹤0.01%	2370
2021 Q1	$20K	Buy	+114	New	+$23K	﹤0.01%	2282

Other funds holding GOCO

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GCM

Glendon Capital Management Santa Monica, California $805M AUM 17.91% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Macquarie Group's GOCO Position: Q4 2021 in Review

Macquarie Group sold out of GoHealth (GOCO) in Q4 2021, closing a stake of 1,932 shares — an estimated $146K sold.

Macquarie Group first reported a position in GOCO in Q1 2021 and held it in 3 quarters. The position peaked at $146K in Q3 2021. 124 funds tracked by Wall St. Rank hold GOCO as of Q4 2021.

Macquarie Group reported no remaining GoHealth position as of Q4 2021 after selling out during the quarter.
Macquarie Group sold 1,932 GoHealth shares in Q4 2021, an estimated $146K.
Macquarie Group first reported a position in GoHealth in Q1 2021 and held it in 3 quarters.
Macquarie Group's GoHealth position peaked at $146K in Q3 2021.
124 funds tracked by Wall St. Rank held GoHealth as of Q4 2021.

Based on Macquarie Group's 13F filing for Q4 2021, filed 11 Feb 2022.